December 22, 2020 Non Regulatory LIDDS has decided to apply for listing of the company’s shares on Nasdaq Stockholm Main Market in 2021
December 18, 2020 Non Regulatory Update on Chinese Conditional Market Approval (CMA) for Liproca® Depot
November 18, 2020 Non Regulatory A review article defines LIDDS as a key player in TLR9 agonist research field and being the only provider having a sustained release product in development
October 19, 2020 Non Regulatory LIDDS announces outcome of subscription of shares in the incentive programs 2017/2020
January 14, 2020 Non Regulatory LIDDS: The United States Patent and Trademark Office has registered the LIDDS trademark NANOZOLID in the US
January 13, 2020 Non Regulatory LIDDS: Stockpicker´s buy recommendation for 2020 picks LIDDS share as one of twelve attractive Swedish companies